Story perspectives

Louisiana Challenges FDA Abortion Pill Changes in Lawsuit

2/25/2026

Summary

Story summary

Louisiana filed a response in a lawsuit challenging the FDA's 2023 changes to abortion pill regulations.
Louisiana argues the changes facilitate nearly 1,000 illegal abortions monthly through mail-order prescriptions.
Louisiana seeks a preliminary stay of the 2023 regulations.
Louisiana claims the FDA actions violate the Comstock Act and undermine state laws protecting unborn children.
Louisiana Attorney General Liz Murrill emphasizes accountability against illegal mailings of abortion pills.

1 of 1

Story summary

Louisiana filed a response in a lawsuit challenging the FDA's 2023 changes to abortion pill regulations.
Louisiana argues the changes facilitate nearly 1,000 illegal abortions monthly through mail-order prescriptions.
Louisiana seeks a preliminary stay of the 2023 regulations.
Louisiana claims the FDA actions violate the Comstock Act and undermine state laws protecting unborn children.
Louisiana Attorney General Liz Murrill emphasizes accountability against illegal mailings of abortion pills.